Investor FAQ

BioNTech was founded in 2008 in Mainz, Germany.

We are incorporated under the laws of the European Union and the Federal Republic of Germany.

BioNTech went public in October 2019.

Our fiscal year ends on December 31. Our fiscal quarters end on March 31, June 30, September 30 and December 31.

Our common stock is listed on the Nasdaq Global Select Market under the ticker symbol BNTX.

Ernst & Young GmbH
Wirtschaftsprüfungsgesellschaft

Covington & Burling LLP

It is BNY Mellon. Please find the contact details below:

Telephone Queries:
BNY Mellon’s DR Broker Solutions Desk
London: +44 207 163 7427
New York: +1 212 815 2267

Mail Queries:
Regular mail:
BNY Mellon
PO Box 505000
Louisville, KY 40233-5000

Overnight/certified/registered delivery:
BNY Mellon
462 South 4th Street, Suite 1600
Louisville, KY 40202

BioNTech’s press release archive can be viewed at: https://investors.biontech.de/press-releases

Our financial reports are available at: https://investors.biontech.de/financials/overview